Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • Log out
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Original Articles

Role for Autonomic Nervous System to Increase Pancreatic Glucagon Secretion During Marked Insulin-Induced Hypoglycemia in Dogs

  1. Peter J Havel,
  2. Richard C Veith,
  3. Beth E Dunning and
  4. Gerald J Taborsky Jr
  1. Department of Physiological Sciences, School of Veterinary Medicine, and Department of Nutrition, University of California-Davis Davis, California; and Departments of Medicine and Psychiatry and Behavioral Sciences, University of Washington, and Veterans Administration Medical Center Seattle, Washington.
  1. Address correspondence and reprint requests to Peter J. Havel, Department of Physiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616.
Diabetes 1991 Sep; 40(9): 1107-1114. https://doi.org/10.2337/diab.40.9.1107
PreviousNext
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

To determine the role of the autonomic nervous system (ANS) in mediating the glucagon response to marked insulin-induced hypoglycemia in dogs, we measured arterial and pancreatic venous glucagon responses to insulin-induced hypoglycemia during acute, terminal experiments in halothane-anesthetized dogs in which the ANS was intact (control; n = 9), pharmacologically blocked by the nicotinic ganglionic antagonist hexamethonium (n = 6), or surgically ablated by cervical vagotomy and cervical spinal cord section (n = 6). In control dogs, insulin injection caused plasma glucose to fall by 4.4 ± 0.2 mM to a nadir of 1.7 ± 0.2 mM. Arterial epinephrine (EPI) levels increased by 13,980 ± 1860 pM (P < 0.005), confirming marked activation of the ANS. Pancreatic output of glucagon increased from 0.53 ± 0.12 to 2.04 ± 0.38 ng/min during hypoglycemia (change [Δ] + 1.51 ± 0.33 ng/min, P < 0.005). This increased arterial plasma glucagon from 27 ± 3 to 80 ± 15 ng/L (Δ + 52 ± 14 ng/L, P < 0.025). Hexamethonium markedly reduced the ANS response to insulin injection (ΔEPI + 2130 ± 600 pM, P < 0.025 vs. control) despite a similar fall of plasma glucose (Δ −4.1 ± 0.2 mM) and a lower nadir (0.6 ± 0.1 mM). Both the pancreatic glucagon response (delta glucagon output +0.45 ± 0.2 ng/min) and the arterial immunoreactive glucagon response (Δ + 5 ± 4 ng/L) were substantially reduced by hexamethonium (P < 0.025). Vagotomy plus spinal cord section totally abolished the arterial EPI response to insulin injection despite a larger fall of plasma glucose (Δ −5.4 ± 0.4 mM) and a lower nadir (0.9 ± 0.2 mM). Again, both the pancreatic glucagon response (Δglucagon output +0.27 ± 0.23 ng min) and the arterial glucagon response (Δ +5 ± 2 ng/L) were significantly reduced (both P < 0.025 vs. control). We conclude that autonomic activation contributes to the glucagon response to marked insulin-induced hypoglycemia in dogs.

  • Received May 24, 1990.
  • Revision received March 28, 1991.
  • Accepted March 28, 1991.
  • Copyright © 1991 by the American Diabetes Association
PreviousNext
Back to top

In this Issue

September 1991, 40(9)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Role for Autonomic Nervous System to Increase Pancreatic Glucagon Secretion During Marked Insulin-Induced Hypoglycemia in Dogs
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Role for Autonomic Nervous System to Increase Pancreatic Glucagon Secretion During Marked Insulin-Induced Hypoglycemia in Dogs
Peter J Havel, Richard C Veith, Beth E Dunning, Gerald J Taborsky
Diabetes Sep 1991, 40 (9) 1107-1114; DOI: 10.2337/diab.40.9.1107

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Role for Autonomic Nervous System to Increase Pancreatic Glucagon Secretion During Marked Insulin-Induced Hypoglycemia in Dogs
Peter J Havel, Richard C Veith, Beth E Dunning, Gerald J Taborsky
Diabetes Sep 1991, 40 (9) 1107-1114; DOI: 10.2337/diab.40.9.1107
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Intravitreal Triamcinolone Acetonide Inhibits Breakdown of the Blood-Retinal Barrier Through Differential Regulation of VEGF-A and Its Receptors in Early Diabetic Rat Retinas
  • Improved Glucose Tolerance in Zucker Fatty Rats by Oral Administration of the Dipeptidyl Peptidase IV Inhibitor Isoleucine Thiazolidide
  • Fibronectin Fragments Modulate Human Retinal Capillary Cell Proliferation and Migration
Show more Original Articles

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.